Aidapak Recalls Vitamin B Complex Tablets Due to Labeling Errors
Aidapak Services, LLC is recalling Vitamin B Complex Prolonged Release tablets because they may be mislabeled as guaiFENesin ER or tolterodine tartrate ER.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling mixup. Per the rubric, minor labeling errors and voluntary precautionary recalls without reported injuries fall under the Moderate severity category.
Plain-English summary
Aidapak Services, LLC is recalling 120-count bottles of Vitamin B Complex Prolonged Release Tablets (NDC 40985022251) due to a labeling error. The recalled product may be incorrectly labeled as guaiFENesin ER, Tablet, 600 mg (NDC 63824000815) or TOLTERODINE TARTRATE ER, Capsule, 4 mg (NDC 00009519101).
The affected lots have pedigree codes AD73627_26 with an expiration date of 5/30/2014, and AD76686_1 with an expiration date of 5/31/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers should check their medication labels and stop using the product if it matches the recalled description. They should contact their pharmacist or healthcare provider for guidance on proper disposal or replacement.
The recalled product
- Product
- VITAMIN B COMPLEX PROLONGED RELEASE Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 40985022251
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-the-Counter
- Hazard
- Affected units
- 120
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- EXP: 5/30/2014
- Pedigree: AD76686_1
- EXP: 5/31/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Tolterodine Tartrate ER Capsules Due to Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Vitamin B Complex Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateFDA Recalls Lithium Carbonate ER Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateFDA Recalls Bumetanide Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Cyanocobalamin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Niacin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29